Key statistics
As of last trade, Immunocore Holdings PLC (6YG:FRA) traded at 31.20, 18.18% above the 52 week low of 26.40 set on Sep 25, 2024.
52-week range
Open | 30.20 |
---|---|
High | 31.60 |
Low | 30.20 |
Bid | 31.20 |
Offer | 31.60 |
Previous close | 30.40 |
Average volume | 0.00 |
---|---|
Shares outstanding | 50.03m |
Free float | 44.70m |
P/E (TTM) | -- |
Market cap | 1.61bn USD |
EPS (TTM) | -0.9494 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 18:55 GMT.
More ▼
- Immunocore to present at upcoming investor conferences
- Immunocore reports third quarter financial results and provides a business update
- EQS-News: BB Biotech: Strategic reallocation of portfolio assets progressing
- Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer
- Immunocore to present at the 2024 Cantor Global Healthcare Conference
- Immunocore announces transition of Chief Financial Officer
- Immunocore reports second quarter financial results and provides a business update
- Immunocore to report second quarter 2024 financial results and host call on August 8, 2024
- Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma
- Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response
More ▼